FDA Inspection 1236701 — Dr. Louis R. Manara
The FDA completed an inspection of Dr. Louis R. Manara on March 26, 2024 in Voorhees, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 26, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Voorhees, NJ (United States)